KENNETH REAY CODE - 14 Jul 2025 Form 4 Insider Report for BIOLARGO, INC. (BLGO)

Role: Chief Science Officer, Director
Signature: /s/ John R. Browning, attorney-in-fact
Issuer symbol: BLGO
Transactions as of: 14 Jul 2025
Net transactions value: +$36,251
Form type: 4
Filing time: 16 Jul 2025, 18:21:17 UTC
Previous filing: 03 Jan 2025
Next filing: 17 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
CODE KENNETH REAY	Chief Science Officer, Director	14921 CHESTNUT ST., WESTMINSTER	/s/ John R. Browning, attorney-in-fact	16 Jul 2025	0001370684

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BLGO	Common Stock	Award	$36,251	+181,253	+0.73%	$0.2000	25,131,495	14 Jul 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares and acquisition price per share).
F2	Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation.